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Abstract: Current primary care patterns for chronic obstructive pulmonary disease (COPD) 
focus on reactive care for acute exacerbations, often neglecting ongoing COPD management to 
the detriment of patient experience and outcomes. Proactive diagnosis and ongoing multifacto-
rial COPD management, comprising smoking cessation, influenza and pneumonia vaccinations, 
pulmonary rehabilitation, and symptomatic and maintenance pharmacotherapy according to 
severity, can significantly improve a patient’s health-related quality of life, reduce exacerba-
tions and their consequences, and alleviate the functional, utilization, and financial burden of 
COPD. Redesign of primary care according to principles of the chronic care model, which is 
implemented in the patient-centered medical home, can shift COPD management from acute 
rescue to proactive maintenance. The chronic care model and patient-centered medical home 
combine delivery system redesign, clinical information systems, decision support, and self-
management support within a practice, linked with health care organization and community 
resources beyond the practice. COPD care programs implementing two or more chronic care 
model components effectively reduce emergency room and inpatient utilization. This review 
guides primary care practices in improving COPD care workflows, highlighting the contributions 
of multidisciplinary collaborative team care, care coordination, and patient engagement. Each 
primary care practice can devise a COPD care workflow addressing risk awareness, spiromet-
ric diagnosis, guideline-based treatment and rehabilitation, and self-management support, to 
improve patient outcomes in COPD.
Keywords: chronic obstructive pulmonary disease, chronic care model, patient-centered medical 
home, self-management, interdisciplinary care team, coordination of care
Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive yet preventable and 
treatable disease characterized by incompletely reversible airway obstruction, cough, 
dyspnea, and phlegm. COPD is often associated with tobacco smoking and/or air-
borne particulate exposures (eg, workplace contaminants, biomass smoke, or urban 
air pollution) but may also reflect inherited α-antitrypsin deficiency and/or idiopathic 
causes.1,2 Current care patterns for COPD reflect reactive “rescue care,” in which health 
professionals and patients seldom interact except during episodes of acute illness,3 such 
as exacerbations (worsening of COPD symptoms, which affect patients’ functioning 
and require a change in management). An exacerbation emergency is often the first 
presentation of previously undiagnosed but symptomatic COPD, which may progress 
to severe disease before patients seek care,4,5 especially in patients who seldom attend 
or have insufficient access to primary care. Because COPD exacerbations are major International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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drivers of COPD progression,6 functional deficits,7 health 
care utilization,8 and cost burden,9 rescue care alone is not 
optimal for COPD.10 Acute care for emergent COPD exac-
erbations is insufficient to maintain patients’ functioning or 
affect the disease course,10 a punctuated equilibrium in which 
each successive exacerbation can accelerate respiratory 
decline.6 Proactive diagnosis and management before the first 
exacerbation occurs can reduce exacerbation incidence and 
severity and improve outcomes.10 Chronic care redesign, to 
refocus primary practice toward proactive maintenance, can 
improve care for COPD and other ambulatory-care-sensitive 
conditions (in which hospitalization rates rise as primary care 
becomes less accessible and/or adequate).11
Proactive, multifactorial COPD care – including smoking 
cessation, vaccinations, physical activity, and maintenance 
pharmacotherapy to reduce future exacerbations – can 
lessen the physical, care-utilization, and financial burdens of 
COPD.1,2 Physicians can uncover unacknowledged symptoms 
of COPD by inquiring about patients’ reductions in activity 
as well as overt dyspnea.12 Primary care questionnaires and 
other tools aid identification of candidates for spirometry.13,14 
Spirometry can be effectively performed in primary care 
practices to conclusively diagnose COPD,15 and is an essential 
tool for confirming COPD and distinguishing it from other 
respiratory diseases.
Primary care of COPD can benefit from application of 
Wagner’s chronic care model (CCM)16 as implemented 
in the patient-centered medical home (PCMH).17 These 
approaches seek to transform care delivery from a rescue 
orientation to a planned-care orientation3 and to empower 
patients and families to collaborate actively with the health 
care team.18 Core aspects of the CCM within a practice 
include delivery system redesign (eg, for advanced access 
to same-day primary care appointments), clinical infor-
mation systems, decision support for clinicians (such as 
point-of-care guideline reminders), and support for patient 
self-management.18 Additional aspects concern coordina-
tion with health care organizations outside the practice (eg, 
accountable care organizations integrating specialty and 
inpatient care with chronic primary care to achieve care 
coordination and cost savings)19,20 and linkage to community 
resources.18 The medical home concept has existed since 
1967, when it was developed to coordinate pediatric care 
for children with special needs.17 More recently the PCMH 
has been articulated as a broad framework for transforming 
primary care for patients of all ages. Society signatories 
to the 2007 Joint Principles of the PCMH17 include the 
American Academy of Family Practice, American Academy 
of Pediatrics, American College of Physicians (ACP), and 
American Osteopathic Association;17 the American Medi-
cal Association subsequently ratified the Joint Principles.21 
Through the Patient-Centered Primary Care Collaborative, 
a multitude of other professional organizations support the 
PCMH; just a few examples include the American Colleges 
of Osteopathic Family Physicians and Osteopathic Inter-
nists, ACP, American Academies of Nurse Practitioners 
and Physician Assistants, and American Board of Internal 
Medicine. Figure 1 gives an overview of PCMH principles 
applied to COPD care. Additionally, in 2010 the ACP enun-
ciated principles for the PCMH neighbor,22 a conceptual 
framework for specialty practices collaborating with the 
PCMH in patient care.
CCM implementations for COPD including at least 
two aspects of Wagner’s model have been shown to reduce 
inpatient and emergency utilization.23 Successful chronic 
care requires both practice redesign and patient engagement. 
Informing and activating patients is indispensable but not 
sufficient. Third-party disease management programs or other 
interventions targeted purely to patients are attractive to payers 
because of perceived cost savings and to practices because of 
perceived economy of effort. However, chronic care programs 
that also transform practice organizational culture have greater 
impact than those requiring the patients to do all the changing.24 
Collaborative multidisciplinary care teams within a practice 
and care coordination with inpatient, emergency, and specialty 
services beyond primary care practice walls are particularly 
important for improving COPD management.
This review article aims to provide practical methods 
and examples for implementing proactive primary care 
workflows for patients with COPD, focusing particularly on 
the CCM principles of multidisciplinary team collaboration, 
care coordination, and patient activation.
Planned care for COPD:  
changing practice focus  
from rescue to maintenance
The CCM was developed to free primary care from the 
“tyranny of the urgent,”18,25 in which acute concerns crowd 
out chronic conditions for priority in time-limited primary 
care visits. Proactive maintenance of chronic disease includ-
ing COPD requires protected resources: multidisciplinary 
care teams allowing division of labor between acute and 
chronic care, and scheduled well-care visits supported by 
previsit planning and providing dedicated chronic care time.3 
Additionally, since office visits represent a tiny fraction of International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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patients’ time,25 the CCM strives to activate and educate 
patients to take care of themselves between visits in the 
community they live in.
Planned COPD visits should be dedicated solely to COPD 
maintenance and may include individual patients or groups of 
patients; visits involving medication management or patient 
education may be conducted by a nurse or clinical pharma-
cist using physician-written protocols or standing orders.3 
Each chronic care visit should have a specific agenda (eg, 
spirometry and disease staging, pharmacotherapy initiation, 
inhaler training, patient education, establishment of smoking 
cessation pharmacotherapy and support, and physical activ-
ity planning), so that all aspects of COPD management are 
consciously targeted.
COPD maintenance in primary care should reflect current 
COPD guidelines.1,2,26 Practices can create simple tools (eg, 
visit templates and task grids) to embody guideline essentials 
in daily workflow; use of electronic medical records (EMRs) 
linking each visit to patients’ known histories also facilitates 
opportunistic respiratory follow-up when patients with known 
or suspected COPD visit the practice for other reasons.25
Guideline-based management of spirometrically diag-
nosed stable COPD comprises risk reduction, symptomatic 
and maintenance pharmacotherapy, and pulmonary rehabili-
tation, as well as additional interventions for severe or very 
severe disease (oxygen therapy, surgery, and palliative care). 
The Global Initiative for Obstructive Lung Disease (GOLD) 
20101 and American Thoracic Society/European Respiratory 
Society (ATS/ERS) 2004 guidelines2 address management 
of stable COPD and exacerbations, whereas the 2011 ACP/
American College of Chest Physicians/ATS/ERS update 
(ACP/ACCP/ATS/ERS)26 focuses on diagnosis and manage-
ment of stable COPD.
Risk reduction measures appropriate throughout the 
course of COPD include smoking cessation and influenza 
vaccination for all patients and pneumonia vaccination for 
senior patients.1,2 Pharmacotherapy is generally   prescribed 
according to COPD severity and symptoms. Short-acting 
bronchodilators (GOLD 2010 specifies short-acting 
β-adrenergic agonists) may be used for symptom relief at 
any stage of COPD.1,2 Maintenance therapy with long-acting 
antimuscarinic or β-adrenergic agents is recommended 
beginning at moderate disease (GOLD 2010),1 for persistent 
symptoms (ATS/ERS 2004),2 or at forced expiratory volume 
in 1 second (FEV1) , 60% predicted (ACP/ACCP/ATS/
ERS 2011).26 The latter guidelines also suggest maintenance 
treatment in symptomatic patients with FEV1 between 60% 
and 80% predicted, while calling for further research in this 
disease stage.26 Inhaled corticosteroids are not preferred as 
monotherapy,1,26 but may be added to maintenance treatment 
for more advanced disease and repeated exacerbations.1,2 
ACP/ACCP/ATS/ERS 2011 suggests that clinicians may 
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Figure 1 Key aspects of the patient-centered medical home applied to chronic obstructive pulmonary disease (COPD) care.
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administer combination therapies to symptomatic patients 
with FEV1 , 60% predicted while weighing potential   benefits 
and harms on a case-by-case basis.26
GOLD 2010 includes the recently US-approved oral 
phosphodiesterase inhibitor roflumilast and states that, “In 
patients with Stage III: Severe COPD or Stage IV: Very 
Severe COPD and a history of exacerbations and chronic 
bronchitis, roflumilast reduces exacerbations treated with 
oral glucocorticosteroids.”1
Pulmonary rehabilitation is recommended by GOLD 
20101 to begin in moderate disease, by ATS 20042 for patients 
with respiratory symptoms and functional limitations, and by 
ACP/ACCP/ATS/ERS 201126 for symptomatic patients with 
FEV1 , 50%. ACP/ACCP/ATS/ERS 201126 further states 
that clinicians may consider pulmonary rehabilitation for 
symptomatic or exercise-limited patients with FEV1 . 50%. 
All three guidelines provide additional therapies for severe 
and very severe COPD: long-term oxygen in hypoxic severe 
disease, and possible surgical referral in very severe emphy-
sematous COPD.1,2,26
GOLD-recommended long-acting maintenance treat-
ments include the long-acting β-adrenergic bronchodilators 
salmeterol or formoterol, their corticosteroid combina-
tions salmeterol/fluticasone or formoterol/budesonide, and 
the long-acting antimuscarinic agent tiotropium. Two of 
these maintenance regimens, tiotropium and salmeterol/
fluticasone, are approved by the US Food and Drug Admin-
istration to reduce exacerbations of COPD. Tiotropium is 
approved “for the once-daily, maintenance treatment of 
bronchospasm associated with COPD”27 and “to reduce 
exacerbations in COPD patients,”27 and salmeterol/flutica-
sone is approved “for the twice-daily maintenance treatment 
of airflow obstruction in patients with COPD”28 and “to 
reduce exacerbations of COPD in patients with a history of 
exacerbations.”28 Indacaterol, a long-acting β-adrenergic 
agonist, received FDA approval in 2011 “for the long term, 
once-daily maintenance bronchodilator treatment of airflow 
obstruction in patients with COPD, including chronic bron-
chitis and/or emphysema.”29
Chronic care toolbox for COPD
Tools for proactive primary care of COPD include a time-
line of care tasks for the first year or more after diagnosis, 
task grids for division of labor among a multidisciplinary 
care team, checklists for assuring that the right care takes 
place at the right time, metrics for tracking improvement in 
COPD care processes and outcomes, and an intrapractice 
COPD patient registry that can be readily developed from 
meaningful EMR use.
A basic model of the COPD patient journey used in the 
author’s work with the educational Group Practice Forum is 
shown in Figure 2. Practices can customize a workflow to fit 
their available resources and patients’ needs; core features 
include spirometric diagnosis when a patient presents with 
suspected COPD, a physician-directed care plan, a designated 
COPD coordinator who handles patient intake, follow-up, 
and COPD registry use by means of the EMR, and provision 
of comprehensive in-person and online patient education 
within the first year after diagnosis.
Task assignment across the care team will look different 
depending on practice size and resources. Even a solo prac-
tice with one physician and one nurse benefits from regular 
planned shared reflection and conscious division of labor.30 
A large group practice will have available many types of 
professionals, eg, physicians, medical assistants, registered 
nurses, nurse practitioners, physician assistants, registered 
respiratory therapists and physical therapists, dieticians, and/
or clinical pharmacists. Successful collaborative care teams 
assign tasks based on actual skill sets and ensure that every 
team member works at the highest skill level permitted by 
licensing.
Nursing professionals (from medical assistants through 
licensed practical nurses, registered nurses, and nurse practi-
tioners) have many potential touch points with patients, such 
as autonomous office visits or home visits not requiring a 
physician, electronic visits, and/or group COPD education 
sessions. An ideal task apportionment amongst the COPD 
team distributes tasks throughout the care team rather than 
concentrating them upon physicians. Additionally, nurses 
Office
visit
Office
visit
Office
visit
Office
visit
Office
visit
Office
visit
Office
visit
Office
visit
COPD patient
diagnosed at
routine physician
visit
COPD
coordinator
EMR
COPD
coordinator
Physician-led
education
treatment plan
COPD online
educator
GMA
PATIENT
EDUCATION
EMR
COPD
coordinator
EMR
Office
visit
Office
visit
Follow-up 6
months after
diagnosis
Follow-up 1
year after
diagnosis
Follow-up 3
months later
Clinical
care team
EMR
Figure 2 Sample patient journey for chronic obstructive pulmonary disease (COPD).
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can provide needed follow-up to patients between visits, 
  answering questions, teaching and monitoring inhaler 
  technique, and assisting adherence.
A COPD coordinator (the author’s practice places a 
registered nurse in this role) can handle new COPD patient 
intake, treatment planning under long-range physician 
guidance, EMR use, and health literacy assessment and 
follow-up comprising self-management teaching, medi-
cation adherence assessment, and depression screening. 
Assignment of respiratory care specialists and specially 
trained registered respiratory therapists or registered nurses 
to management of COPD at Baylor University’s lung pro-
gram multiplied rates of spirometry use (26% to 100% in 
internal medicine and 4% to 100% in geriatrics; P , 0.05 
for both) and documented inhaler training (13% to 90% in 
internal medicine, P , 0.05).31 Staff members who them-
selves are coping with asthma or COPD (or have affected 
relatives) make excellent peer-educators and champions 
for inhaler technique.
A practice COPD registry facilitates planned care, 
longitudinal follow-up, and improvement at the level of 
the practice’s COPD population. Registry contents can be 
developed by using EMR capabilities to identify all patients 
with diagnosed or suspected COPD and to track COPD-care-
related metrics, such as receipt of spirometry, lung function 
parameters, guideline-appropriate treatment, physical activ-
ity levels, exacerbation incidence/frequency, and resulting 
care utilization. Simpler registries are more sustainable than 
complex ones, especially at first. Patients may be allowed 
to access their own registry information via a secure Web 
portal to facilitate self-management; patients may even be 
allowed to enter patient-reported information, eg, on exacer-
bation triggers and incidence, as-needed inhaler usage levels, 
and physical activities. Web views for care team members 
within the practice can be configured to allow viewing and 
management of benchmark indicators for the entire COPD 
patient population.
Metrics allow the practice to track important processes 
and outcomes of COPD care and provide continuous feedback 
that permits continuous improvement. Plan-Do-Study-Act 
cycles can be as simple as a solo physician and practice nurse 
discussing a process improvement, trying it immediately, and 
discussing the results a week later.30 Plan-Do-Study-Act is 
useful for incremental process improvements;32 however, 
practice-wide transformation to PCMH methodology often 
entails multiple interdependent changes exceeding the scope 
of Plan-Do-Study-Act.33 Within-practice metrics facilitate 
process and outcome improvement; externally visible metrics 
often inform compensation. Currently, COPD care has fewer 
publicly reportable metrics than, for example, diabetes care, 
placing COPD at a disadvantage in pay-for-performance 
programs.34 Ideally, metrics should be selected on the basis 
of evidence for their contribution to clinical improvement. 
The diabetes experience indicates that ease of measurement 
does not necessarily predict impact on patient outcomes.35 
Possible metrics for COPD care include levels of utilization 
of the COPD-Population Screener™13 or other risk-awareness 
questionnaires, spirometry utilization, treatment guideline 
adherence (eg, maintenance inhaler treatment for patients 
at or beyond moderate COPD),1 and primary care follow-up 
rates promptly after an exacerbation-related emergency 
room (ER) or inpatient episode.36 Presentation of metrics in 
chronological order with effective graphics allows immedi-
ate visualization of trends and areas needing improvement. 
The author’s practice uses a COPD dashboard visualizing 
patients’ individual metrics for the patient-accessible Web 
portal and the practice’s COPD population metrics for the 
in-clinic professional view. Whether metrics measure care 
processes or the resulting outcomes, all should contribute to 
the ultimate goal of improving outcomes for patients with 
COPD (eg, increased activity levels and medication adher-
ence, reduced exacerbation rates, reduced ER and hospital 
visits, and improved follow-up during transitions to and 
from hospital).
CCM and PCMH methods invite practices to reconcep-
tualize their workflow to make optimal use of the unique 
combination of skills in each practice’s multidisciplinary care 
team. This team comprises not only the practice’s various 
professionals but also enlists patients themselves.
From passive recipients to active 
participants: transforming patients’ 
behavior
Patient training for self-management is an essential part 
of chronic care, and particularly of COPD management. 
However, purely didactic prePCMH models of patient edu-
cation need to give way to those focused on practical skills 
and behavioral change. Disease knowledge is an overused 
outcome of chronic care or self-management programs for 
COPD. Published COPD chronic care programs with knowl-
edge as their main measured outcome are more numerous 
but less effective than comprehensive self-management 
interventions addressing education and health literacy, moti-
vation, and behavioral changes.23 Engagement of patients 
and families to take an active role in managing their health 
is central to the CCM.16International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Self-management support, including COPD   exacerbation 
action plans and proactive professional follow-up by tele-
phone as well as education, has been shown to reduce health 
care utilization requirements. Among 743 US veterans with 
severe COPD randomized to receive either usual care or 
a self-management intervention comprising 1.5 hours of 
initial education, a plan for self-care of exacerbations, and a 
monthly call from a case manager, self-management support 
significantly reduced COPD-related and other cardiopulmo-
nary hospitalizations, any-cause hospitalizations, and any-
cause ER visits versus usual care.37 A similar program with 
more extensive education (8 weekly professional education 
visits, exacerbation action plan, and telephone follow-up) 
in a Canadian randomized trial in severe COPD reduced 
hospitalizations by 39.8%, ER visits by 41.0%, and unsched-
uled physician visits by 57.1% versus control.38 Proactive 
integrated care including 3 months’ home telemonitoring of 
daily spirometry, pulse oximetry, pedometry, and symptoms 
identified unreported exacerbations in moderate-to-severe 
COPD and significantly improved health-related quality of 
life versus usual care.39
The concept of remote COPD patient support has been 
extended into a variety of schemes for telehealthcare, in 
which electronic interactions between patients and care 
team members allow for various combinations of education, 
adherence improvement, patient data collection, electronic 
care visits, early detection and management of exacerbations, 
reduction of unscheduled office and ER visits, or rehospital-
ization prevention.40 Telehealthcare for COPD was shown in 
a recent Cochrane Database review40 to significantly reduce 
ER visits and hospitalizations versus usual care. A limitation 
of the review was that telehealthcare was frequently embed-
ded in more complex integrated care interventions, thus most 
reviewed studies did not test the effect of telehealthcare in 
isolation.
Pulmonary rehabilitation provides aerobic exercise 
training, psychosocial interaction, and education to patients 
with COPD. It is recommended to begin with moderate 
disease (GOLD),1 symptomatic disease (ATS/ERS),2 or at 
FEV1 , 50% (though suggested for symptomatic, exercise-
limited patients of FEV1 . 50% predicted; ACP/ACCP/ATS/
ERS 2011),26 but pulmonary rehabilitation has been shown 
to improve respiratory and/or physical functioning in any 
stage of COPD.41 Home-based pulmonary rehabilitation has 
been shown to improve patient-reported dyspnea similarly to 
in-center pulmonary rehabilitation in patients with   moderate 
to severe COPD.42 Several long-acting inhaled   maintenance 
therapies, eg, tiotropium,43 salmeterol,44 formoterol,45 
  budesonide/formoterol,46 salmeterol/fluticasone,47 or tiotro-
pium plus salmeterol/fluticasone,48 have been shown to 
improve patients’ ability to exercise, and combining main-
tenance therapy with formal pulmonary rehabilitation has 
improved exercise outcomes beyond those obtained with 
pulmonary rehabilitation alone.43,49
Beyond the specific interventions of patient education 
and pulmonary rehabilitation, clinicians face the challenge 
of enlisting patients to collaborate actively in managing 
their COPD. Where the concept of compliance focuses nar-
rowly on patients following doctors’ orders to take medica-
tions, concordance engages patients in their daily lives and 
environments – where they live, work, and play – to craft 
a comprehensive and sustainable lung-friendly lifestyle.50 
Establishing concordance involves engaging patients 
where they currently are on the arc of acceptance of their 
disease. In dealing with a new COPD diagnosis, patients 
often experience stages of grief – denial, anger, bargaining, 
depression – on their way to acceptance, and their decisions 
about smoking cessation and other self-care may be compli-
cated by this process. Anxiety and reluctance to acknowl-
edge COPD-related limitations are related to nonadherence 
with therapy and poor respiratory and functional coping.51 
Depression adversely affects coping with COPD including 
therapy adherence; training in problem-solving skills may 
improve adherence in elderly COPD patients.52 Smokers 
may often admit the risks of smoking in general but tacitly 
believe that they themselves are not personally susceptible 
to lung damage. Confrontational counseling for smoking 
cessation, communicating spirometric evidence of airflow 
limitation, decreased participants’ denial and increased both 
their perception of risk and their confidence in their ability 
to quit (self-efficacy), thus improving cessation rates versus 
conventional health promotion.53 Motivational interviewing 
is an effective tool for lifestyle change; it has been shown 
to help in smoking cessation54 and concurrent depression 
management,55 to enhance self-management of COPD,56 and 
to improve adherence to medication.57 The most powerful 
self-management programs incorporate robust interven-
tions, such as cognitive-behavioral therapy and treatment 
of comorbid depression.23
Adherence and persistence with medication are crucial 
to therapeutic effectiveness. The “brown bag” technique, in 
which a patient brings all their medications to a primary care 
appointment and describes how the medications are taken, 
allows a care team member (eg, clinical pharmacist) to moni-
tor adherence and reconcile potential interactions or errors 
at every visit.58 Inhaler technique is important in achieving International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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COPD treatment effectiveness; yet inhaler misuse remains 
prevalent even among experienced users of respiratory medi-
cations.59 Poor maintenance inhaler technique is   associated 
with increased inpatient and emergency care utilization 
and greater need for systemic steroids and   antibiotics.59 
Practices need to assign inhaler technique teaching to a 
specific   champion and build it consistently into their COPD 
workflow,60 and patients need to build medication use into 
their own unique daily lives. Routinized medication taking 
in tandem with a consistent daily activity (eg, brushing of 
teeth) assists adherence.61
Care coordination: smoothing 
transitions and maintaining 
continuity
In addition to other aspects of the CCM, care coordina-
tion and transition management beyond the confines of the 
primary practice are crucial to successful chronic care for 
COPD. Providing all professionals (within the practice and 
in other referral or inpatient/ER settings) the same up-to-
date information about each patient fosters continuity of 
care and reduces misunderstandings and rework. Referrals 
(eg, to pulmonologists, pulmonary function labs, and other 
specialists such as cardiologists) are increasingly needed as 
COPD advances; in a PCMH, processes must be in place 
for arranging referrals, receiving specialists’ reports, and 
following up with patients.62 Availability and efficiency of 
referrals does not necessarily correlate with the size or con-
nectivity of a care organization outside the primary practice, 
but does depend critically on all appropriate employees hav-
ing access to the same accurate information about clinicians’ 
availability and patients’ needs. Integrated and accountable 
care organizations form patient-centered medical villages 
for the PCMH, in which specialty expertise is appropriately 
accessed by primary physician and patient while supply-
sensitive overuse is avoided.19,20 Pulmonary rehabilitation 
may be practice-based, accountable care organization-based, 
or referred externally.
Specialist practices that collaborate with referring PCMH 
primary practices may become PCMH neighbors with 
processes ensuring appropriate, timely consultations and 
referrals, sharing information bidirectionally with a PCMH, 
and determining responsibility for each aspect of collabora-
tive patient care.22 Interactions between the specialty clinic 
and PCMH will vary in duration, intensity, and division of 
labor. Types of interactions range from the preconsulta-
tion exchange, eg, “curbside consult” for the primary care 
physician to ask questions informally, through a formal 
time-limited consultation to an ongoing shared   management 
arrangement. In certain severe life-limiting diseases the 
specialist may take on responsibility for principal care. Col-
laboration between a PCMH and specialist neighbor can be 
facilitated by a care coordination agreement that specifies 
contents of a patient transition record, defines expectations 
of information sharing, sets accountability and which practice 
does what care tasks, and clarifies transition processes for 
hospitalization and discharge.22
Attention to transitions to and from the ER or hospital 
can improve care for patients who experience emergent 
exacerbations of COPD. Provision of information from 
primary care to the ER or hospital and proper informa-
tion sharing within inpatient venues can avoid redundant 
questioning of patients or failure to act on important health 
problems.32 In turn, hospitals and ERs should alert primary 
care physicians when patients with known chronic respira-
tory conditions are admitted.32 An 18-month program of 
guided primary care for multimorbid elderly patients led 
by specially trained registered nurses63 achieved signifi-
cant improvements in coordination of care by making the 
guided-care nurse responsible for transition arrangements. 
Hospitalization for an exacerbation may be an opportunity 
to begin guideline-appropriate maintenance treatment.10,64 
Conversely, sometimes hospitalization may interrupt an 
existing maintenance regimen for COPD. Careful medica-
tion reconciliation, and preserving or resuming regimens 
appropriately, is important when patients enter and leave 
the hospital.32 PCMH methodology can improve primary 
care follow-up after a COPD-related ER visit or inpatient 
stay, which in turn can improve postexacerbation outcomes 
for patients. A PCMH demonstration project significantly 
improved the proportion of patients who received follow-up 
communications from their primary care physician within 
3 days after an ER visit.36 Integrated postdischarge care 
after hospitalization for an exacerbation, consisting of an 
individualized plan shared with the primary care team and 
provision of telephone patient support from a nurse case 
manager, improved patients’ recognition and self-care of 
exacerbations and their medication adherence and inhaler 
technique.65
Conclusion
Recent literature indicates that COPD chronic care pro-
grams implementing two or more components of the origi-
nal CCM effectively reduce ER and inpatient utilization. 
Advanced primary care access scheduling and robust self-
management support were the CCM components showing International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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most evidence for benefit in COPD according to a 2007 
systematic review.23 Multidisciplinary collaborative team 
care will be implemented differently in practices of different 
sizes and skill sets; each primary care practice can devise a 
team COPD care workflow that implements essential tasks 
of risk awareness, spirometric diagnosis, guideline-based 
treatment and rehabilitation, and equipping patients for self-
management. Chronic care for COPD must reach beyond the 
primary care practice into patients’ lives in the community 
on the one hand, and into practices’ linkages with specialty, 
ER, and inpatient care on the other. Continuity and com-
munication in care transitions are essential, especially when 
patients are treated for exacerbations in the hospital or ER, 
to maintain ongoing care regimens and respond to changes 
in patients’ respiratory and physical prognosis. Primary care 
practices that expend the effort to transform their approach 
to chronic diseases, including COPD, by using CCM and 
PCMH concepts, reduce utilization burdens and physical/
psychosocial sequelae more effectively than the default 
reactive primary care approach. Patient-centered chronic 
care for COPD promises to improve health-related quality 
of life for patients.
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